NEU 15.1% $16.57 neuren pharmaceuticals limited

Is P/S a good way to compare NEU with other companies when I...

  1. 2,500 Posts.
    lightbulb Created with Sketch. 898
    Is P/S a good way to compare NEU with other companies when I would suggest more than half our value can be attributed to NNZ-2591, which produces no sales? Something a computer written article made up from quantitative data doesn't take into consideration.

    Also, our earnings will be 'lumpy' due to milestone payments but there is no projected 'reduced earnings' if you exclude the one-offs, just reduced 'earnings growth'. Again the computer has no understanding of the nature of milestone payments, only that overall projected earning are less this year, in spite of actual 'sales' continuing to trend up.

    Preaching an article like this as gospel (or relevant in any way) when it is so deeply flawed is a tad silly. I'll leave the goose comment alone.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.57
Change
2.170(15.1%)
Mkt cap ! $2.117B
Open High Low Value Volume
$14.85 $16.67 $14.60 $24.77M 1.544M

Buyers (Bids)

No. Vol. Price($)
1 1500 $16.52
 

Sellers (Offers)

Price($) Vol. No.
$16.57 1717 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.